Shingles Vaccine and Viagra Show Promise as Alzheimer's Treatments
Three existing drugs, including a shingles vaccine, emerge as top candidates for repurposing against Alzheimer's disease.
Parkinson's disease, dopamine pathways, movement disorders, and neuroprotection
109 articles
Three existing drugs, including a shingles vaccine, emerge as top candidates for repurposing against Alzheimer's disease.
UCLA scientists discover why some neurons resist Alzheimer's better than others, revealing a natural protein cleanup system that could lead to new treatments.
Scientists identify how cocaine rewires brain circuits through a protein that acts like a genetic switch, explaining addiction persistence.
New study reveals two-thirds of daily behaviors are automatic habits, offering insights for building healthier routines and breaking bad ones.
Stanford neuroscientist explains how brain circuits drive social connection and why strong relationships are essential for wellbeing.
Neuroscientist Andrew Huberman reveals the brain circuits behind habit formation and practical tools to build lasting behavioral change.
Major study of 28,000 people challenges low-fat advice, finding full-fat dairy may protect brain health in those without genetic risk.
New research reveals statins could reduce dementia risk by 85% in genetically susceptible individuals, offering personalized prevention.
Case study shows how methylmalonic acidemia disrupts dopamine pathways, causing severe movement disorders in adults.
Scientists identify specific brain neurons that control withdrawal symptoms, opening new therapeutic pathways.
Andrew Huberman shares science-backed strategies to optimize dopamine for sustained motivation and enhanced cognitive performance.
Neuroscientist Dr. Read Montague reveals how brain chemicals shape learning, motivation, and the hidden costs of instant gratification.